2630904-45-7

MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA complex, with an IC50 of less than 10 nM in PRMT5/MTA MTAPDEL SDMA cells[1].

Store at -20°C

[1]. Targeting the genetic and immunological drivers of cancer.